Biennial eye screening in patients with diabetes without retinopathy: 10-year experience

Aims: To evaluate the safety of every-other-year eye screening for patients with diabetes without retinopathy. Methods: Since 1994, patients with diabetes without retinopathy in Iceland have received eye screening every other year. 296 patients with diabetes who had no diabetic retinopathy in 1994/9...

Full description

Bibliographic Details
Published in:British Journal of Ophthalmology
Main Authors: Ólafsdóttir, E, Stefánsson, E
Format: Text
Language:English
Published: BMJ Publishing Group Ltd 2007
Subjects:
Online Access:http://bjo.bmj.com/cgi/content/short/91/12/1599
https://doi.org/10.1136/bjo.2007.123810
id fthighwire:oai:open-archive.highwire.org:bjophthalmol:91/12/1599
record_format openpolar
spelling fthighwire:oai:open-archive.highwire.org:bjophthalmol:91/12/1599 2023-05-15T16:50:46+02:00 Biennial eye screening in patients with diabetes without retinopathy: 10-year experience Ólafsdóttir, E Stefánsson, E 2007-12-01 00:00:00.0 text/html http://bjo.bmj.com/cgi/content/short/91/12/1599 https://doi.org/10.1136/bjo.2007.123810 en eng BMJ Publishing Group Ltd http://bjo.bmj.com/cgi/content/short/91/12/1599 http://dx.doi.org/10.1136/bjo.2007.123810 Copyright (C) 2007, BMJ Publishing Group Ltd Clinical science - Scientific reports TEXT 2007 fthighwire https://doi.org/10.1136/bjo.2007.123810 2015-02-28T16:36:25Z Aims: To evaluate the safety of every-other-year eye screening for patients with diabetes without retinopathy. Methods: Since 1994, patients with diabetes without retinopathy in Iceland have received eye screening every other year. 296 patients with diabetes who had no diabetic retinopathy in 1994/95 were followed with biennial eye examinations until they had developed retinopathy. The 10-year experience of this approach is reviewed. Results: Out of the 296 diabetic individuals, 172 did not develop diabetic retinopathy during the 10-year observation period. 96 patients developed mild non-proliferative retinopathy, six developed clinically significant diabetic macular oedema, 23 developed preproliferative retinopathy, and four developed proliferative diabetic retinopathy during the 10-year observation period. All the patients who developed macular oedema or proliferative retinopathy had already been diagnosed as having mild nonproliferative retinopathy and entered an annual screening protocol before the sight-threatening retinopathy developed. No patient had any undue delay in treatment. Conclusion: Every other year screening for diabetic eye disease seems to be safe and effective in diabetics without retinopathy. Such an approach will reduce the number of screening visits more than 25%. This reduces health costs and strain on resources considerably and relieves the patients with diabetes from unnecessary clinic visits and examinations. Text Iceland HighWire Press (Stanford University) British Journal of Ophthalmology 91 12 1599 1601
institution Open Polar
collection HighWire Press (Stanford University)
op_collection_id fthighwire
language English
topic Clinical science - Scientific reports
spellingShingle Clinical science - Scientific reports
Ólafsdóttir, E
Stefánsson, E
Biennial eye screening in patients with diabetes without retinopathy: 10-year experience
topic_facet Clinical science - Scientific reports
description Aims: To evaluate the safety of every-other-year eye screening for patients with diabetes without retinopathy. Methods: Since 1994, patients with diabetes without retinopathy in Iceland have received eye screening every other year. 296 patients with diabetes who had no diabetic retinopathy in 1994/95 were followed with biennial eye examinations until they had developed retinopathy. The 10-year experience of this approach is reviewed. Results: Out of the 296 diabetic individuals, 172 did not develop diabetic retinopathy during the 10-year observation period. 96 patients developed mild non-proliferative retinopathy, six developed clinically significant diabetic macular oedema, 23 developed preproliferative retinopathy, and four developed proliferative diabetic retinopathy during the 10-year observation period. All the patients who developed macular oedema or proliferative retinopathy had already been diagnosed as having mild nonproliferative retinopathy and entered an annual screening protocol before the sight-threatening retinopathy developed. No patient had any undue delay in treatment. Conclusion: Every other year screening for diabetic eye disease seems to be safe and effective in diabetics without retinopathy. Such an approach will reduce the number of screening visits more than 25%. This reduces health costs and strain on resources considerably and relieves the patients with diabetes from unnecessary clinic visits and examinations.
format Text
author Ólafsdóttir, E
Stefánsson, E
author_facet Ólafsdóttir, E
Stefánsson, E
author_sort Ólafsdóttir, E
title Biennial eye screening in patients with diabetes without retinopathy: 10-year experience
title_short Biennial eye screening in patients with diabetes without retinopathy: 10-year experience
title_full Biennial eye screening in patients with diabetes without retinopathy: 10-year experience
title_fullStr Biennial eye screening in patients with diabetes without retinopathy: 10-year experience
title_full_unstemmed Biennial eye screening in patients with diabetes without retinopathy: 10-year experience
title_sort biennial eye screening in patients with diabetes without retinopathy: 10-year experience
publisher BMJ Publishing Group Ltd
publishDate 2007
url http://bjo.bmj.com/cgi/content/short/91/12/1599
https://doi.org/10.1136/bjo.2007.123810
genre Iceland
genre_facet Iceland
op_relation http://bjo.bmj.com/cgi/content/short/91/12/1599
http://dx.doi.org/10.1136/bjo.2007.123810
op_rights Copyright (C) 2007, BMJ Publishing Group Ltd
op_doi https://doi.org/10.1136/bjo.2007.123810
container_title British Journal of Ophthalmology
container_volume 91
container_issue 12
container_start_page 1599
op_container_end_page 1601
_version_ 1766040890527186944